MSD acquires WuXi's vaccine facility in Dundalk for €500m

The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China

The MSD site in Dundalk, Co Louth. The Dundalk site will become part of the company’s network of five, large-scale pharma manufacturing sites

China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD Ireland in a €500m deal.

The acquisition is expected to be completed in the first half of this year and will bring to eight the number ofMSD sites in Ireland.